Technical Feasibility and Performance Evaluation of a Smart Adherence Pillbox for Tuberculosis Treatment

Authors

  • Rian Nurahman Universitas Harapan Bangsa Purwokerto Author
  • Ikhwan Yuda Kusuma Universitas Harapan Bangsa Purwokerto Author
  • Peppy Octaviani Universitas Harapan Bangsa Purwokerto Author
  • Silma Kaaffah Universitas Harapan Bangsa Purwokerto Author

Keywords:

Tuberculosis, Smart Pillbox, Digital Health, Prototype Validation

Abstract

Tuberculosis (TB) remains a major global health challenge, with poor medication adherence contributing to treatment failure and the rise of multidrug-resistant TB. Digital adherence technologies, including smart pillboxes, show promise, but evidence of their technical reliability remains limited. This study aimed to evaluate the technical feasibility and functional performance of the Smart-Adherence Pillbox (SAP) prototype. A prototype validation study was conducted using 100 repeated simulated cycles in a controlled environment without patient involvement. The device was assessed across multiple domains, including alarm system performance, dispensing accuracy, connectivity, mechanical safety, and notification logging. Performance was analyzed using descriptive statistics, with success rates and 95% confidence intervals, while temporal metrics were summarized as mean ± standard deviation, median, and range. The SAP prototype demonstrated high functional reliability, with success rates ranging from 99.0% to 100% across all domains. Alarm accuracy reached 99.0%, while dispensing, connectivity, mechanical safety, and notification functions achieved 100% success. Temporal analysis showed no deviation in alarm activation and logging, with rapid notification delivery (mean 2.05 seconds). However, data transfer time showed variability (mean 7.57 seconds; range 2–41 seconds), indicating potential network-related delays. Minor issues, such as delayed transfers and simulated missed-dose events, were observed but did not impact overall system performance. The SAP prototype demonstrated excellent technical feasibility and reliability under controlled conditions. Further clinical studies are required to evaluate its effectiveness in real-world TB treatment adherence.

References

[1] WHO, Global Tuberculosis Report 2024, 1st ed. Geneva: World Health Organization, 2024.

[2] J. Espinosa-Pereiro, A. Sánchez-Montalvá, M. Aznar, and M. Espiau, “MDR Tuberculosis Treatment,” Medicina (Mex.), vol. 58, 2022, [Online]. Available: https://pdfs.semanticscholar.org/b00e/1c000abe7356da1ed26bfc3880746bae7e26.pdf

[3] L. Rosu et al., “Cost of digital technologies and family-observed DOT for a shorter MDR-TB regimen: a modelling study in Ethiopia, India and Uganda,” BMC Health Serv. Res., vol. 23, 2023, [Online]. Available: https://api.semanticscholar.org/CorpusId:265278892

[4] M. Mundakir, A. Asri, and S. Winata, “Community-based Management and Control of Tuberculosis in Sub-urban Surabaya, Indonesia: A Qualitative Study,” Open Access Maced. J. Med. Sci., vol. 9, pp. 212–217, 2021.

[5] Q. Xian et al., “Protocol for the sonogenetic stimulation of mouse brain by non-invasive ultrasound,” STAR Protoc., vol. 2, 2021, [Online]. Available: https://api.semanticscholar.org/CorpusId:232479284

[6] WHO, Global Tuberculosis Report 2023, 1st ed. Geneva: World Health Organization, 2023.

[7] R. A. Davis, H. B. Leavitt, A. Singh, E. Fanouraki, R. W. Yen, and R. W. Bratches, “Examining interventions that aim to enhance TB treatment adherence in Southeast Asia: A systematic review and meta-analysis,” Indian J. Tuberc., vol. 71, no. 1, pp. 48–63, 2024.

[8] X. Liu et al., “Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial,” Lancet Glob. Health, vol. 11, no. 5, pp. e693–e703, 2023.

[9] D. S. A. Minaam and M. Abd-ELfattah, “Smart drugs: Improving healthcare using smart pill box for medicine reminder and monitoring system,” Future Comput. Inform. J., vol. 3, no. 2, pp. 443–456, 2018.

[10] I. M. A. Mahardiananta, I. M. A. Nugraha, G. P. Reganata, and I. G. M. N. Desnanjaya, “Perancangan Alat Bantu Kotak Obat Berbasis Mikrokontroler Dalam Peningkatan Kepatuhan Meminum Obat Pada Pasien TBC,” Resist. Elektron. Kendali Telekomun. Tenaga List. Komput., vol. 5, no. 1, pp. 65–72, 2022.

[11] S. C. J. Charles et al., “Enhancing Tuberculosis Treatment Adherence: Evaluating the Efficacy of the Support for Treatment Adherence and Medication Protocols (STAMP) Device for Automatic Dispensing and Real-Time Medication Monitoring,” Cureus, vol. 16, no. 9, 2024.

[12] S. Han et al., “Participant Adherence in Repeated-Dose Clinical Studies Using Video-Based Observation: Retrospective Data Analysis,” JMIR MHealth UHealth, vol. 13, 2024, [Online]. Available: https://api.semanticscholar.org/CorpusId:277612876

[13] D. Wallace, S. Ganna, and R. Aparasu, “Validation of the Sensal Health MyAideTM Smart Dock Medication Adherence Device,” Pharmacy, vol. 13, 2025, [Online]. Available: https://api.semanticscholar.org/CorpusId:281060330

[14] T. Nunes et al., “Deployment and validation of a smart bed architecture for untethered patients with wireless biomonitoring stickers,” Med. Biol. Eng. Comput., vol. 62, pp. 3815–3840, 2024.

[15] H. Lim, J. Han, M. Park, J. Y. Kim, H. Pak, and S. Oh, “Feasibility of smart ring-based remote monitoring in hospitalized patients: evaluation of signal transmission latency and data acquisition continuity,” Front. Bioeng. Biotechnol., vol. 13, 2025, [Online]. Available: https://api.semanticscholar.org/CorpusId:283948508

[16] A. Serhane, R. Raad, W. Susilo, and M. Raad, “Applied methods to detect and prevent vulnerabilities within PLC alarms code,” SN Appl. Sci., vol. 4, 2022, [Online]. Available: https://api.semanticscholar.org/CorpusId:247859070

[17] M. Aguilar-Rivera et al., “Smart Electronic Eyedrop Bottle for Unobtrusive Monitoring of Glaucoma Medication Adherence,” Sensors, vol. 20, 2020, [Online]. Available: https://api.semanticscholar.org/CorpusId:218499116

[18] N. Bionghi et al., “Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa,” BMC Infect. Dis., vol. 18, 2018, [Online]. Available: https://api.semanticscholar.org/CorpusId:4886077

[19] R. Subbaraman et al., “Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities,” BMJ Glob. Health, vol. 3, 2018, [Online]. Available: https://api.semanticscholar.org/CorpusId:53084095

[20] J. Zhou et al., “Randomized clinical trial of a digital medication system to enhance adherence in patients with severe mental disorders,” NPJ Digit. Med., vol. 8, 2025, [Online]. Available: https://api.semanticscholar.org/CorpusId:279158720

[21] D. Evans, R. Berhanu, F. Moyo, A. Nguweneza, L. Long, and M. Fox, “Can Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa,” AIDS Behav., vol. 20, pp. 2717–2728, 2016.

[22] T. Salam et al., “Cooperative Dew Computing for Computational Offloading in Healthcare Monitoring,” IEEE Access, vol. 12, pp. 170041–170056, 2024.

[23] B. Tasca et al., “Factors Related to the Utilization of Digital Adherence Technologies in Tuberculosis Care: A Qualitative Study Among Adults in DS-TB Treatment, Health Care Providers and Other Key Stakeholders in Tanzania,” in medRxiv, 2023. [Online]. Available: https://api.semanticscholar.org/CorpusId:266422305

[24] A. Cattamanchi et al., “Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomizedtrial in Uganda,” PLoS Med., vol. 18, 2021, [Online]. Available: https://pdfs.semanticscholar.org/1594/6c2a8c477cb2044325f0a59e9404ebce3aec.pdf

[25] S. Charalambous et al., “Treatment adherence and clinical outcomes amongst in people with drug-susceptible tuberculosis using medication monitor and differentiated care approach compared with standard of care in South Africa: a cluster randomized trial,” eClinicalMedicine, vol. 75, 2024, [Online]. Available: https://api.semanticscholar.org/CorpusId:271518064

[26] T. Stuart et al., “Biosymbiotic platform for chronic long-range monitoring of biosignals in limited resource settings,” Proc. Natl. Acad. Sci. U. S. A., vol. 120, 2023, [Online]. Available: https://api.semanticscholar.org/CorpusId:265657787

Downloads

Published

2026-05-08

How to Cite

Technical Feasibility and Performance Evaluation of a Smart Adherence Pillbox for Tuberculosis Treatment. (2026). Proceeding International Conference on Multidisciplinary Engagement, 1(1), 578-585. https://prosiding.gerakanedukasi.com/index.php/income/article/view/131

Most read articles by the same author(s)

Similar Articles

31-31 of 31

You may also start an advanced similarity search for this article.